People channel feed

With KRAS break­through on the hori­zon, Am­gen's David Reese re­flects on so­tora­si­b's loom­ing re­view date and murky fu­ture

5 years ago
R&D

Spark co-founder Kathy High joins a long­time col­lab­o­ra­tor at AskBio, help­ing steer Bay­er's gene ther­a­py push

5 years ago
Cell/Gene Tx

Ed­i­tas Med­i­cine's sci­ence head Al­bright leaves for new job just as biotech gets tri­al clear­ance for sick­le cell ther­a­py

5 years ago
FDA+

DBV re­struc­tur­ing claims 200 jobs as it beats out a path to­ward peanut patch OK

5 years ago

Af­ter an up-and-down year, Nek­tar watch­es de­vel­op­ment head Wei Lin walk away as it pur­sues pipeline re­bound

5 years ago

Au­to­lus buck­les down, chop­ping 20% of staff and seek­ing part­ner for a lead CAR-T pro­gram

5 years ago

Eliz­a­beth Nabel steps down as pres­i­dent of Brigham and Wom­en's Hos­pi­tal to team up with hus­band's biotech joint — re­port

5 years ago

Re­gen­eron's Schleifer, Yan­copou­los set their com­pa­ny's am­bi­tions sky high with $1.4B on the ta­ble in per­for­mance awards

5 years ago

Mace Rothen­berg starts the year by step­ping out of his top job in Pfiz­er R&D — as Stan­ford’s Ai­da Habtezion steps in

5 years ago

Lynn Seely hits the ex­it as My­ovant grad­u­ates to com­mer­cial space — hand­ing the reins to Am­gen vet

5 years ago

Trump par­dons Chris Collins, for­mer con­gress­man im­pris­oned for biotech in­sid­er trad­ing scan­dal

5 years ago

Pe­ter Thiel joins fund­ing round for pep­tide drug play­er in lat­est swing at emerg­ing biotech mar­ket

5 years ago
Financing

For­mer J&J VP sues phar­ma gi­ant for discim­i­na­tion and ha­rass­ment, ac­cus­es top ex­ecs — in­clud­ing Alex Gorsky — of re­tal­i­at­ing against her

5 years ago

Sam­sung Bi­o­log­ics pro­motes new CEO from with­in to head next phase of rapid man­u­fac­tur­ing ex­pan­sion

5 years ago
Outsourcing

Al­ny­lam trail­blaz­er Bar­ry Greene jumps to the helm of a strug­gling Sage Ther­a­peu­tics. Can he de­liv­er an­oth­er come­back?

5 years ago

Bob Nelsen ex­its board and pres­i­dent steps down at Uni­ty as fall­out from the an­ti-ag­ing biotech's PhII miss con­tin­ues

5 years ago
Pharma

Sarep­ta shakes up C-suite as they pre­pare to test FDA on Duchenne again

5 years ago

Mass­Bio head Cough­lin set to step down af­ter over­see­ing mas­sive bio­phar­ma ex­pan­sion in the state dur­ing 13-year tenure

5 years ago
R&D

Long­time In­ter­cept CEO Mark Pruzan­s­ki de­parts as ail­ing NASH com­pa­ny tries to find its fu­ture

5 years ago

New York law­suit again ac­cus­es Mar­tin Shkre­li of ma­nip­u­la­tion from be­hind bars

5 years ago
Pharma

Spe­cial re­port: Twen­ty ex­tra­or­di­nary women blaz­ing trails in bio­phar­ma R&D — Covid-19 and be­yond

5 years ago
Special

Af­ter build­ing pipelines from Glax­o­SmithK­line to Flag­ship, Paul Pe­ter Tak takes the helm at an un­der-the-radar on­colyt­ic virus play­er

5 years ago

Carl Hansen is just about ready to grab the key to the ex­clu­sive Cov­il­lion­aire club

5 years ago
Bioregnum
Opinion

Af­ter tak­ing on phar­ma M&A, 'pay-for-de­lay' and Gilead­'s remde­sivir pric­ing, Cal­i­for­nia AG tapped to lead HHS — re­ports

5 years ago
First page Previous page 62636465666768 Next page Last page
A service from the Financial Times